1769 related articles for article (PubMed ID: 10790990)
21. Pharmacological treatment of attention-deficit/hyperactivity disorder in adults.
Slatkoff J; Greenfield B
Expert Opin Investig Drugs; 2006 Jun; 15(6):649-67. PubMed ID: 16732717
[TBL] [Abstract][Full Text] [Related]
22. Stimulant medication therapy in the treatment of children with attention deficit hyperactivity disorder.
Stevenson RD; Wolraich ML
Pediatr Clin North Am; 1989 Oct; 36(5):1183-97. PubMed ID: 2677938
[TBL] [Abstract][Full Text] [Related]
23. Effectiveness of attention-deficit/hyperactivity treatment and diagnosis methods tested.
Rep Med Guidel Outcomes Res; 2000 Feb; 11(4):1-2, 5-7. PubMed ID: 11768409
[No Abstract] [Full Text] [Related]
24. Diagnosis and treatment of attention deficit hyperactivity disorder (ADHD).
NIH Consens Statement; 1998 Nov 16-18; 16(2):1-37. PubMed ID: 10868163
[TBL] [Abstract][Full Text] [Related]
25. Blood pressure changes associated with medication treatment of adults with attention-deficit/hyperactivity disorder.
Wilens TE; Hammerness PG; Biederman J; Kwon A; Spencer TJ; Clark S; Scott M; Podolski A; Ditterline JW; Morris MC; Moore H
J Clin Psychiatry; 2005 Feb; 66(2):253-9. PubMed ID: 15705013
[TBL] [Abstract][Full Text] [Related]
26. Comparative efficacy and acceptability of atomoxetine, lisdexamfetamine, bupropion and methylphenidate in treatment of attention deficit hyperactivity disorder in children and adolescents: a meta-analysis with focus on bupropion.
Stuhec M; Munda B; Svab V; Locatelli I
J Affect Disord; 2015 Jun; 178():149-59. PubMed ID: 25813457
[TBL] [Abstract][Full Text] [Related]
27. Long-Term Pharmacotherapy of Adults With Attention Deficit Hyperactivity Disorder: A Literature Review and Clinical Study.
Fredriksen M; Peleikis DE
Basic Clin Pharmacol Toxicol; 2016 Jan; 118(1):23-31. PubMed ID: 26404187
[TBL] [Abstract][Full Text] [Related]
28. Methylphenidate dosing: twice daily versus three times daily.
Stein MA; Blondis TA; Schnitzler ER; O'Brien T; Fishkin J; Blackwell B; Szumowski E; Roizen NJ
Pediatrics; 1996 Oct; 98(4 Pt 1):748-56. PubMed ID: 8885956
[TBL] [Abstract][Full Text] [Related]
29. Attention deficit hyperactivity disorder in adults.
Rösler M; Casas M; Konofal E; Buitelaar J
World J Biol Psychiatry; 2010 Aug; 11(5):684-98. PubMed ID: 20521876
[TBL] [Abstract][Full Text] [Related]
30. Long-term efficacy and safety of treatment with stimulants and atomoxetine in adult ADHD: a review of controlled and naturalistic studies.
Fredriksen M; Halmøy A; Faraone SV; Haavik J
Eur Neuropsychopharmacol; 2013 Jun; 23(6):508-27. PubMed ID: 22917983
[TBL] [Abstract][Full Text] [Related]
31. Impact of comorbid autism spectrum disorders on stimulant response in children with attention deficit hyperactivity disorder: a retrospective and prospective effectiveness study.
Santosh PJ; Baird G; Pityaratstian N; Tavare E; Gringras P
Child Care Health Dev; 2006 Sep; 32(5):575-83. PubMed ID: 16919137
[TBL] [Abstract][Full Text] [Related]
32. Attention-deficit-hyperactivity disorder: an update.
Dopheide JA; Pliszka SR
Pharmacotherapy; 2009 Jun; 29(6):656-79. PubMed ID: 19476419
[TBL] [Abstract][Full Text] [Related]
33. Attention-deficit hyperactivity disorder.
Calis KA; Grothe DR; Elia J
Clin Pharm; 1990 Aug; 9(8):632-42. PubMed ID: 1974836
[TBL] [Abstract][Full Text] [Related]
34. How efficacious and safe is short-acting methylphenidate for the treatment of attention-deficit disorder in children and adolescents? A meta-analysis.
Schachter HM; Pham B; King J; Langford S; Moher D
CMAJ; 2001 Nov; 165(11):1475-88. PubMed ID: 11762571
[TBL] [Abstract][Full Text] [Related]
35. Pemoline treatment of adolescents with attention deficit hyperactivity disorder: a short-term controlled trial.
Bostic JQ; Biederman J; Spencer TJ; Wilens TE; Prince JB; Monuteaux MC; Sienna M; Polisner DA; Hatch M
J Child Adolesc Psychopharmacol; 2000; 10(3):205-16. PubMed ID: 11052410
[TBL] [Abstract][Full Text] [Related]
36. Side effects of methylphenidate and dexamphetamine in children with attention deficit hyperactivity disorder: a double-blind, crossover trial.
Efron D; Jarman F; Barker M
Pediatrics; 1997 Oct; 100(4):662-6. PubMed ID: 9310521
[TBL] [Abstract][Full Text] [Related]
37. Non-pharmacological interventions for attention-deficit/hyperactivity disorder (ADHD) delivered in school settings: systematic reviews of quantitative and qualitative research.
Richardson M; Moore DA; Gwernan-Jones R; Thompson-Coon J; Ukoumunne O; Rogers M; Whear R; Newlove-Delgado TV; Logan S; Morris C; Taylor E; Cooper P; Stein K; Garside R; Ford TJ
Health Technol Assess; 2015 Jun; 19(45):1-470. PubMed ID: 26129788
[TBL] [Abstract][Full Text] [Related]
38. Duration of effect of oral long-acting stimulant medications for ADHD throughout the day.
Brams M; Moon E; Pucci M; López FA
Curr Med Res Opin; 2010 Aug; 26(8):1809-25. PubMed ID: 20491612
[TBL] [Abstract][Full Text] [Related]
39. Pharmacotherapy of attention-deficit/hyperactivity disorder in adults.
Wender PH
J Clin Psychiatry; 1998; 59 Suppl 7():76-9. PubMed ID: 9680056
[TBL] [Abstract][Full Text] [Related]
40. Bupropion for attention deficit hyperactivity disorder (ADHD) in adults.
Verbeeck W; Bekkering GE; Van den Noortgate W; Kramers C
Cochrane Database Syst Rev; 2017 Oct; 10(10):CD009504. PubMed ID: 28965364
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
